AJP - Endocrinology and Metabolism, Vol 269, Issue 2 E199-E207, Copyright © 1995 by American Physiological Society

ARTICLES

Impact of infection on hepatic disposal of a peripheral glucose infusion in the conscious dog

O. P. McGuinness, J. Jacobs, C. Moran and B. Lacy
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232-0615, USA.

The effect of infection on hepatic uptake and disposal of a continuous (180-min) intravenous glucose infusion (8 mg.kg-1.min-1) was examined in conscious, 54-h-fasted, chronically catheterized dogs. Thirty-six hours before a study, either infection was induced by implantation of an Escherichia coli-containing (INF; 2 x 10(9) organisms/kg body wt; n = 6) fibrinogen clot, or a sterile (SH; n = 6) clot was implanted into the peritoneal cavity. Hepatic glucose metabolism was assessed using tracer ([3-3H]glucose and [U-14C]glucose) and arteriovenous difference techniques. Infection increased the basal rate of glucose appearance (45%); glucose levels were not altered. In response to glucose infusion, average blood glucose levels increased to similar levels (140 +/- 9 vs. 147 +/- 11 mg/dl in INF and SH, respectively), whereas arterial insulin levels were higher in the infected group during the last hour of the glucose infusion (77 +/- 10 vs. 41 +/- 5 microU/ml in INF vs. SH). Infection impaired net hepatic glucose uptake (0.6 +/- 0.5 and 2.7 +/- 0.7 mg.kg-1.min-1 in INF and SH; P < 0.05). The liver remained a persistent lactate consumer (4.1 +/- 1.8 mumol.kg-1.min-1), whereas the sham group became a net producer of lactate (-3.8 +/- 1.3 mumol.kg-1.min-1). Infection decreased net hepatic glycogen deposition by 53%. In conclusion, infection impairs net hepatic glucose uptake and glycogen deposition despite an exaggerated increase in insulin levels.

This article has been cited by other articles:

				S.-S. Chen, C. M. Donmoyer, D. A. Pearson, A. Poole, Y. Zhang, D. B. Lacy, and O. P. McGuinness Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E286 - E295. [Abstract] [Full Text] [PDF]

				C. M. Donmoyer, J. Ejiofor, D. B. Lacy, S.-S. Chen, and O. P. McGuinness Fructose augments infection-impaired net hepatic glucose uptake during TPN administration Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E703 - E711. [Abstract] [Full Text] [PDF]

				C. M. Donmoyer, S.-S. Chen, S. A. Hande, D. B. Lacy, J. Ejiofor, and O. P. McGuinness Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E235 - E243. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, J. Ejiofor, D. B. Lacy, and N. Schrom Hepatic glucose metabolism during intraduodenal glucose infusion: impact of infection Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E108 - E115. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, C. Donmoyer, J. Ejiofor, S. McElligott, and D. B. Lacy Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E763 - E769. [Abstract] [Full Text] [PDF]